Malin Corporation | MLC - Ebitda

Stock Price
7.45
Daily Change
-0.15 -1.97%
Monthly
-6.88%
Yearly
-12.35%
Q2 Forecast
7.23

Malin Corporation reported EUR-1.1M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
ALKERMES USD 80.26M 20.05M Mar/2026
Avita Medical AUD -9.69M 12.21M Dec/2025
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Eurofins Scientific SE EUR 831M 21M Dec/2025
Ionis Pharmaceuticals USD -200.02M 42.89M Dec/2025
IQVIA Holdings USD 932M 114M Mar/2026
Lonza CHF 1.01B 54M Dec/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Moderna USD -790M 582M Dec/2025
Organon & Co USD 415M 32M Mar/2026
Revvity USD 272.91M 24M Mar/2026
Tectonic Therapeutic USD -21.18M 365K Dec/2025
Viatris USD 1.05B 46.4M Mar/2026
Xeris Pharmaceuticals USD 25.09M 7.67M Dec/2025